BDBM50261730 3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-6-(trifluoromethoxy)quinoline::CHEMBL469040

SMILES Fc1ccc(-c2noc(n2)C2CCN(CC2)c2cnc3ccc(OC(F)(F)F)cc3c2)c(Cl)c1

InChI Key InChIKey=UBZSQBAGAHFYON-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50261730   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50261730(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)
Affinity DataEC50:  3nMAssay Description:Agonist activity at human CB2 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50261730(3-(4-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-...)
Affinity DataEC50:  419nMAssay Description:Agonist activity at human CB1 receptor expressed in insect Sf9 cells assessed as effect on Eu-GTP bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed